ThermoGenesis Holdings, Inc.
(NASDAQ : THMO)

( )
THMO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -2.88%76.640.8%$1071.33m
TMOThermo Fisher Scientific, Inc. -2.88%275.441.0%$865.21m
MDTMedtronic Plc -6.71%84.130.6%$856.00m
BDXBecton, Dickinson & Co. -1.91%225.381.1%$653.90m
ISRGIntuitive Surgical, Inc. -7.46%458.262.4%$652.39m
DHRDanaher Corp. -6.84%128.940.7%$641.66m
SYKStryker Corp. -13.17%144.571.3%$521.61m
BSXBoston Scientific Corp. -7.54%30.171.1%$467.64m
INOInovio Pharmaceuticals, Inc. 3.50%7.706.8%$449.25m
EWEdwards Lifesciences Corp. -8.34%172.891.2%$391.50m
DXCMDexCom, Inc. -5.37%254.818.2%$369.80m
BAXBaxter International, Inc. -3.25%78.551.8%$360.64m
ZBHZimmer Biomet Holdings, Inc. -11.20%89.761.7%$242.29m
IDXXIDEXX Laboratories, Inc. -4.78%230.663.8%$234.81m
ALGNAlign Technology, Inc. -9.63%157.206.4%$225.34m

Company Profile

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.